Abstract
Biological sulfation reactions require 3′-phosphoadenosine-5′-phosphosulfate (PAPS) as the universal sulfate donor. While the biosynthetic pathway of PAPS has been well characterized, the phosphatase degrading PAPS remains unidentified. Here, we discover MESH1 as a PAPS phosphatase that hydrolyzes PAPS into adenosine-5′-phosphosulfate and phosphate. Our crystallographic analysis of the MESH1–PAPS complex confirms PAPS as a bona fide substrate of MESH1. We further show that MESH1 localizes to Golgi, where sulfotransferases consume PAPS to produce sulfated glycosaminoglycan (sGAG). We show that MESH1 (also known as HDDC3) knockdown enhances sGAG production in a chondrogenic cell line. Furthermore, in brachymorphic mice, Mesh1 knockout significantly elevates sGAG levels in joint cartilage and improves bone density. In Caenorhabditis elegans lacking bpnt-1, neurotoxic PAP accumulation is alleviated by MESH1 overexpression, reducing upstream PAPS levels. Our biochemical, structural and functional findings establish MESH1 as a key PAPS phosphatase and highlights its potential as a therapeutic target in disorders characterized by sulfation deficiency.

This is a preview of subscription content, access via your institution
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$32.99 / 30 days
cancel any time
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to the full article PDF.
USD 39.95
Prices may be subject to local taxes which are calculated during checkout




Similar content being viewed by others
Data availability
The atomic coordinates and structure factors for the hMESH1-D66K–PAPS complex were deposited to the Protein Data Bank (PDB) under accession code 9CHY. Additional data underlying the graphs and quantitative analyses presented in this manuscript are provided in the Supplementary Information. Uncropped immunoblots and full microscopy fields are provided in the Supplementary Information. Data are available from the corresponding authors upon request. Source data are provided with this paper.
References
Klaassen, C. D. & Boles, J. W. Sulfation and sulfotransferases 5: the importance of 3′-phosphoadenosine 5′-phosphosulfate (PAPS) in the regulation of sulfation. FASEB J. 11, 404–418 (1997).
Xu, Y. et al. Effect of estrogen sulfation by SULT1E1 and PAPSS on the development of estrogen-dependent cancers. Cancer Sci. 103, 1000–1009 (2012).
Mueller, J. W., Gilligan, L. C., Idkowiak, J., Arlt, W. & Foster, P. A. The regulation of steroid action by sulfation and desulfation. Endocr Rev. 36, 526–563 (2015).
Xu, Z.-H. et al. Human 3′-phosphoadenosine 5′-phosphosulfate synthetase 1 (PAPSS1) and PAPSS2: gene cloning, characterization and chromosomal localization. Biochem. Biophys. Res. Commun. 268, 437–444 (2000).
Xu, Z.-H., Thomae, B. A., Eckloff, B. W., Wieben, E. D. & Weinshilboum, R. M. Pharmacogenetics of human 3′-phosphoadenosine 5′-phosphosulfate synthetase 1 (PAPSS1): gene resequencing, sequence variation, and functional genomics. Biochem. Pharmacol. 65, 1787–1796 (2003).
Xu, Z.-H., Freimuth, R. R., Eckloff, B., Wieben, E. & Weinshilboum, R. M. Human 3′-phosphoadenosine 5′-phosphosulfate synthetase 2 (PAPSS2) pharmacogenetics: gene resequencing, genetic polymorphisms and functional characterization of variant allozymes. Pharmacogenetics 12, 11–21 (2002).
Parkinson, A., Ogilvie, B. W., Buckley, D. B., Kazmi, F. & Parkinson, O. in Casarett and Doull’s Toxicology: The Basic Science of Poisons (ed. Klaassen, C. D.) (McGraw Hill, 2012).
Frederick, J. P. et al. A role for a lithium-inhibited Golgi nucleotidase in skeletal development and sulfation. Proc. Natl Acad. Sci. USA 105, 11605–11612 (2008).
Hudson, B. H. & York, J. D. Roles for nucleotide phosphatases in sulfate assimilation and skeletal disease. Adv. Biol. Regul. 52, 229–238 (2012).
Thiele, H. et al. Loss of chondroitin 6-O-sulfotransferase-1 function results in severe human chondrodysplasia with progressive spinal involvement. Proc. Natl Acad. Sci. USA 101, 10155–10160 (2004).
Murguia, Belles, J. & Serrano, R. A salt-sensitive 3′(2′),5′-bisphosphate nucleotidase involved in sulfate activation. Science 267, 232–234 (1995).
Ramaswamy, S. G. & Jakoby, W. B. (2′)3′,5′-Bisphosphate nucleotidase. J. Biol. Chem. 262, 10044–10047 (1987).
Hudson, B. H. et al. Role for cytoplasmic nucleotide hydrolysis in hepatic function and protein synthesis. Proc. Natl Acad. Sci. USA 110, 5040–5045 (2013).
Meisel, J. D. & Kim, D. H. Inhibition of lithium-sensitive phosphatase BPNT-1 causes selective neuronal dysfunction in C. elegans. Curr. Biol. 26, 1922–1928 (2016).
Potrykus, K. & Cashel, M. (p)ppGpp: still magical? Annu. Rev. Microbiol. 62, 35–51 (2008).
Anderson, B. W., Fung, D. K. & Wang, J. D. Regulatory themes and variations by the stress-signaling nucleotide alarmones (p)ppGpp in bacteria. Annu. Rev. Genet. 55, 115–133 (2021).
Ronneau, S. & Hallez, R. Make and break the alarmone: regulation of (p)ppGpp synthetase/hydrolase enzymes in bacteria. FEMS Microbiol. Rev. 43, 389–400 (2019).
Fernandez-Coll, L. & Cashel, M. Possible roles for basal levels of (p)ppGpp: growth efficiency vs. surviving stress. Front. Microbiol. 11, 592718 (2020).
Bisiak, F. et al. Structural variations between small alarmone hydrolase dimers support different modes of regulation of the stringent response. J. Biol. Chem. 298, 102142 (2022).
Qiu, D. et al. Bacterial pathogen infection triggers magic spot nucleotide signaling in Arabidopsis thaliana chloroplasts through specific RelA/SpoT homologues. J. Am. Chem. Soc. 145, 16081–16089 (2023).
Sun, D. et al. A metazoan ortholog of SpoT hydrolyzes ppGpp and functions in starvation responses. Nat. Struct. Mol. Biol. 17, 1188–1194 (2010).
Dai, X. et al. ppGpp is present in, and functions to regulate sleep of, Drosophila. hLife 1, 98–114 (2023).
Ito, D. et al. ppGpp functions as an alarmone in metazoa. Commun. Biol. 3, 671 (2020).
Ding, C.-K. C. et al. MESH1 is a cytosolic NADPH phosphatase that regulates ferroptosis. Nat. Metab. 2, 270–277 (2020).
Stockwell, B. R. et al. Ferroptosis: a regulated cell death nexus linking metabolism, redox biology, and disease. Cell 171, 273–285 (2017).
Dixon, S. J. et al. Ferroptosis: an iron-dependent form of nonapoptotic cell death. Cell 149, 1060–1072 (2012).
Lin, C. C. et al. The regulation of ferroptosis by MESH1 through the activation of the integrative stress response. Cell Death Dis. 12, 727 (2021).
Sun, T. et al. MESH1 knockdown triggers proliferation arrest through TAZ repression. Cell Death Dis. 13, 221 (2022).
Chi, J. T. & Zhou, P. From magic spot ppGpp to MESH1: stringent response from bacteria to metazoa. PLoS Pathog. 19, e1011105 (2023).
Potrykus, K. et al. Estimates of RelSeq, Mesh1, and SAHMex hydrolysis of (p)ppGpp and (p)ppApp by thin layer chromatography and NADP/NADH coupled assays. Front. Microbiol. 11, 581271 (2020).
Tamman, H. et al. A nucleotide-switch mechanism mediates opposing catalytic activities of Rel enzymes. Nat. Chem. Biol. 16, 834–840 (2020).
Stelzer, C., Brimmer, A., Hermanns, P., Zabel, B. & Dietz, U. H. Expression profile of Papss2 (3′-phosphoadenosine 5′-phosphosulfate synthase 2) during cartilage formation and skeletal development in the mouse embryo. Dev. Dyn. 236, 1313–1318 (2007).
Newton, P. T. et al. Chondrogenic ATDC5 cells: an optimised model for rapid and physiological matrix mineralisation. Int. J. Mol. Med. 30, 1187–1193 (2012).
Hodax, J. K. et al. Aggrecan is required for chondrocyte differentiation in ATDC5 chondroprogenitor cells. PLoS ONE 14, e0218399 (2019).
Miyake, N. et al. PAPSS2 mutations cause autosomal recessive brachyolmia. J. Med. Genet. 49, 533–538 (2012).
Iida, A. et al. Clinical and radiographic features of the autosomal recessive form of brachyolmia caused by 2 mutations. Hum. Mutat. 34, 1381–1386 (2013).
Falany, C. N. Enzymology of human cytosolic sulfotransferases. FASEB J. 11, 206–216 (1997).
Rigueur, D. & Lyons, K. M. Whole-mount skeletal staining. Methods Mol. Biol. 1130, 113–121 (2014).
Sugahara, K. & Schwartz, N. B. Defect in 3′-phosphoadenosine 5′-phosphosulfate formation in brachymorphic mice. Proc. Natl Acad. Sci. USA 76, 6615–6618 (1979).
Orkin, R. W., Pratt, R. M. & Martin, G. R. Undersulfated chondroitin sulfate in the cartilage matrix of brachymorphic mice. Dev. Biol. 50, 82–94 (1976).
Cortes, M., Baria, A. T. & Schwartz, N. B. Sulfation of chondroitin sulfate proteoglycans is necessary for proper Indian hedgehog signaling in the developing growth plate. Development 136, 1697–1706 (2009).
Grunwell, J. R. & Bertozzi, C. R. Carbohydrate sulfotransferases of the GalNAc/Gal/GlcNAc6ST family. Biochemistry 41, 13117–13126 (2002).
Kurima, K. et al. A member of a family of sulfate-activating enzymes causes murine brachymorphism. Proc. Natl Acad. Sci. USA 95, 8681–8685 (1998).
Faiyaz ul Haque, M. et al. Mutations in orthologous genes in human spondyloepimetaphyseal dysplasia and the brachymorphic mouse. Nat. Genet. 20, 157–162 (1998).
Orkin, R. W., Williams, B. R., Cranley, R. E., Poppke, D. C. & Brown, K. S. Defects in the cartilaginous growth plates of brachymorphic mice. J. Cell Biol. 73, 287–299 (1977).
Vanky, P., Brockstedt, U., Nurminen, M., Wikstrom, B. & Hjerpe, A. Growth parameters in the epiphyseal cartilage of brachymorphic (bm/bm) mice. Calcif. Tissue Int. 66, 355–362 (2000).
Boskey, A. L., Maresca, M., Wikstrom, B. & Hjerpe, A. Hydroxyapatite formation in the presence of proteoglycans of reduced sulfate content: studies in the brachymorphic mouse. Calcif. Tissue Int. 49, 389–393 (1991).
Plaas, A. H., West, L. A., Wong-Palms, S. & Nelson, F. R. Glycosaminoglycan sulfation in human osteoarthritis. Disease-related alterations at the non-reducing termini of chondroitin and dermatan sulfate. J. Biol. Chem. 273, 12642–12649 (1998).
Noordam, C. et al. Inactivating PAPSS2 mutations in a patient with premature pubarche. N. Engl. J. Med. 360, 2310–2318 (2009).
Oostdijk, W. et al. PAPSS2 deficiency causes androgen excess via impaired DHEA sulfation—in vitro and in vivo studies in a family harboring two novel PAPSS2 mutations. J. Clin. Endocrinol. Metab. 100, E672–E680 (2015).
Sohaskey, M. L., Yu, J., Diaz, M. A., Plaas, A. H. & Harland, R. M. JAWS coordinates chondrogenesis and synovial joint positioning. Development 135, 2215–2220 (2008).
Vissers, L. E. et al. Chondrodysplasia and abnormal joint development associated with mutations in IMPAD1, encoding the Golgi-resident nucleotide phosphatase, gPAPP. Am. J. Hum. Genet. 88, 608–615 (2011).
Fung, D. K. et al. Metabolic promiscuity of an orphan small alarmone hydrolase facilitates bacterial environmental adaptation. mBio 13, e0242222 (2022).
Acknowledgements
We thank D. Kim for providing the ZD1224 strain that was used in this study. We acknowledge the financial support in part by the DCI Pilot Project, Department of Defense grants to J.T.C. (W81XWH-17-1-0143, W81XWH-15-1-0486, W81XWH-19-1-0842 and W81XWH-20-1-0907) and NIH grants to J.T.C. (R01GM124062, 1R01NS111588-01A1 and 1R21-AI149205). X-ray diffraction data were collected at the Southeast Regional Collaborative Access Team (SER-CAT) 22-BM beamline at the Advanced Photon Source, Argonne National Laboratory. SER-CAT is supported by its member institutions and equipment grants (S10_RR25528, S10_RR028976 and S10_OD027000) from the NIH and funding from the Georgia Research Alliance. This research used resources of the Advanced Photon Source, a US Department of Energy (DOE) Office of Science user facility operated for the DOE Office of Science by Argonne National Laboratory under contract no. W-31-109-Eng-38 and DE-AC02-06CH11357. The graphical abstract and Fig. 4a were created in BioRender; Chi, J. https://biorender.com/yoe9quw and https://biorender.com/j8qkvei (2025).
Author information
Authors and Affiliations
Contributions
C.C.L., P.Z. and J.T.C. designed the research. J.R. solved the X-ray crystallography. J.R. and A.A.M. performed the biochemical studies. C.C.L., A.J.M., S.Y.C. and Y.S. performed the animal studies. C.C.L. performed the cellular studies. A.Z. performed the C. elegans studies. Z.L. performed the MS studies. D.Y., M.J.H., P.Z. and J.T.C. supervised the research. C.K.C., Y.L. and J.W. provided critical feedback and analyzed the data. C.C.L., P.Z. and J.T.C. wrote the first draft of the manuscript, with input from all authors.
Corresponding authors
Ethics declarations
Competing interests
The authors declare no competing interests.
Peer review
Peer review information
Nature Chemical Biology thanks Danny Fung, Abel Garcia-Pino and the other, anonymous, reviewer(s) for their contribution to the peer review of this work.
Additional information
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Extended data
Extended Data Fig. 1 MESH1 overexpression lowered PAPS/APS ratio.
.a, Validation of MESH1 overexpression in HT-1080 cells by western blots. Given MESH1 overexpression was too robust to compare with vector only group, longer exposure time (long expo.) of MESH1 was used to detect endogenous MESH1 protein. b, Mass spectra of PAPS and APS standards. c, Mass spectra of PAPS and APS extracted from HT-1080 cells. d,e, MESH1 overexpression decreased PAPS (d), but not APS (e) levels in HT-1080 cells. Unpaired t-test, n = 3 independent biological replicates, data are mean ± s.d.
Extended Data Fig. 2 Differential recognition of purine metabolites by RelA/SpoT and MESH1.
a, T. thermophilus Rel recognizes the N2 nitrogen of the guanine ring in ppGpp via a hydrogen bond with the carbonyl oxygen of N150 at the C-terminus of the α8 helix (PDB: 6S2T). The helix dipole effect is indicated by the partial charge on the carbonyl group. b, hMESH1 interacts with the N6 nitrogen of the adenine ring in PAPS through a water-mediated hydrogen bond with the carbonyl oxygen of C133 (this work). Of note, N126 of hMESH1, the equivalent residue of N150 in T. thermophilus Rel, forms an intra-helix hydrogen bond, preventing interaction with the N2 nitrogen of guanine. In both panels, proteins are shown in cartoon representation with bound ligands in the stick model. Backbone atoms of α8 (Rel) and α7 (MESH1), along with adjacent loop residues, are shown in stick representation. Hydrogen bonds are depicted as dashed lines, and the hydrogen-bonded water molecule is shown as a sphere.
Extended Data Fig. 3 Golgi-bounded MESH1 regulated sGAG secretion.
a, MESH1 knockdown confirmed the co-localization of MESH1 with Golgi (GM130) in NIH-3T3 cells. b, MESH1 knockdown confirmed the co-localization of MESH1 with Golgi (GM130) in SW1353 cells. c, Validation of MESH1 knockdown as determined by qPCR. d, Differentiated ATDC5 cells with MESH1 knockdown increased GAG secretion as quantified by Alcian blue staining. e-f, MESH1 knockdown increased GAG secretion independent of its NADPH phosphatase activity. Knockout of NADK (e) did not abolish the increase in GAG secretion upon MESH1 knockdown (f). g-i, Differentiated ATDC5 cells with MESH1 knockdown increased the secretion of sulfated proteoglycan, including heparan sulfate (HS) (g), chondroitin-4-sulfate (C4S) (h), and chondroitin-6-sulfate (C6S) (i) as quantified by ImageJ. (c,d,f-i) One-way ANOVA, Tukey’s multiple comparisons, n = 3 independent biological replicates, Data represent mean ± SD.
Extended Data Fig. 4 MESH1 KO mice are viable and fertile.
a, Genotyping results for Mesh1+/a and Mesh1+/+. b, MESH1 expressions (arrow) in Mesh1+/+, Mesh1+/a and Mesh1a/a mice were confirmed in heart, kidney and brain.
Extended Data Fig. 5 MESH1 knockout in mice increased sGAG production and rescued bone density.
a-d, MESH1 knockout did not alter sulfated proteoglycan in the articular cartilage of mice. e, Western blots confirmed the knockout of MESH1 protein in brachymorphic mice. f-h, Quantification showed that Mesh1 knockout increased HS and C6S, but not C4S in the articular cartilage of brachymorphic mice. i, μCT imaging showed the bone density of brachymorphic mice was not rescued by Mesh1 knockout. j, Quantification of bone density as determined by bone volume/total volume (BV/TV) showed Mesh1 knockout did not alter bone density in brachymorphic mice (Papss2bm/bm). (b-d, f-h, j) Unpaired t-test. Data are mean ± SD. (b-d, j) n = 4 independent biological replicates. (f-h) n = 3 independent biological replicates.
Supplementary information
Supplementary Information (download PDF )
Supplementary Tables 1 and 2.
Source data
Source Data Figs. 1, 3 and 4 and Extended Data Figs. 1, 3 and 5 (download XLSX )
Statistical source data.
Source Data Figs. 1 and 3 and Extended Data Figs. 1 and 3–5 (download PDF )
Unprocessed western blots and/or gels.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Lin, CC., Rose, J., Zhang, A. et al. MESH1 functions as a metazoan PAPS phosphatase to regulate sulfation. Nat Chem Biol (2026). https://doi.org/10.1038/s41589-026-02190-5
Received:
Accepted:
Published:
Version of record:
DOI: https://doi.org/10.1038/s41589-026-02190-5


